Publication | Open Access
Pharmacological stimulation of p53 with low-dose doxorubicin ameliorates diet-induced nonalcoholic steatosis and steatohepatitis
34
Citations
22
References
2017
Year
These data provide new evidence for targeting p53 as a strategy to treat liver disease.
| Year | Citations | |
|---|---|---|
Page 1
Page 1